Caesars Entertainment misses Q2 earnings expectations, shares edge lower
Troy D. Weaver, President of Global Refinish at Axalta Coating Systems Ltd . (NYSE:AXTA), a company with an $8 billion market cap and "GOOD" financial health according to InvestingPro, recently executed a series of stock transactions involving the company’s common shares. The company maintains strong fundamentals with a perfect Piotroski Score of 9. On February 10, Weaver sold 10,457 shares at a weighted average price of $37.57, generating proceeds of approximately $392,869. This sale followed a cashless exercise of the same number of vested stock options, which were acquired at an exercise price of $32.50 per share. Notably, while this insider sale occurred, InvestingPro data shows management has been actively buying back shares, suggesting confidence in the company’s outlook.
These transactions resulted in Weaver holding 74,905 shares of Axalta Coating Systems following the sale. The options exercised were originally granted on May 12, 2015, and were set to expire on May 12, 2025. With analysts setting price targets up to $51 and multiple earnings upgrades for the upcoming period, investors can access comprehensive analysis and additional insights through InvestingPro’s detailed research reports.
In other recent news, Axalta Coating Systems has been the subject of several analyst target price adjustments. Mizuho (NYSE:MFG) Securities raised its price target for Axalta to $44, citing the company’s updated financial guidance and recent performance metrics. BMO Capital Markets maintained an Outperform rating on Axalta with a steady price target of $51, highlighting the company’s potential for nearly 40% upside. Citi increased its price target for Axalta to $42, following the company’s recent earnings call.
In addition, Axalta reported Q4 earnings that surpassed analyst expectations, with adjusted earnings per share of $0.60 and revenue of $1.31 billion. The company’s net sales increased 1% year-over-year to $1.3 billion, and net income rose 85% to $137 million. For the full year 2024, Axalta’s net sales increased 2% to $5.3 billion.
Furthermore, Pulse Biosciences (NASDAQ:PLSE) announced the appointment of Jon Skinner, who previously held leadership roles at Axalta, as its new Chief Financial Officer. These are some of the recent developments involving Axalta Coating Systems and Pulse Biosciences.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.